Medroxyprogesterone acetate

CAS 71-58-9

Interested in hearing more about this API?

Medroxyprogesterone Acetate can cause cancer according to The World Health Organization’s International Agency for Research on Cancer (IARC). It can cause developmental toxicity according to state or federal government labeling requirements.

About the API

Technology

High Potent

Therapeutic category

Endocrinology

Regulations

	EU CEP
	US DMF

Systematic Name

[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate

The information detailed herein, including that with regard to active pharmaceutical ingredients , their use in treatments and possible mechanism(s) of action, was all obtained from public sources. For more information on our services and products – including product suitability, intended uses and current availability – please contact Teva api Customer Service. CAS Registry Number is a Registered Trademark of the American Chemical Society. This webpage and any reference to the above product is to be read within the meaning and terms of the Legal Notes.